A clinical abuse potential study of REMOXY ER.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2017
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Adverse reactions; Registrational
- Sponsors Pain Therapeutics
- 06 Nov 2017 According to a Pain Therapeutics media release, trial status is substantially completed.
- 01 Nov 2017 According to a Pain Therapeutics media release, top-line results of this study are expected by year-end 2017.
- 08 Aug 2017 According to a DURECT Corporation media release, Pain Therapeutics expects to complete this trial by year end 2017.